Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Respiratory syncytial virus
Recent news which mentions Respiratory syncytial virus
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 07, 2024
Tags
Business News
Health & Science
GSK plc
From
CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
April 09, 2024
Tags
Science
Business
Pharmaceuticals
From
CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
October 25, 2023
Tags
Immunizations
Pharmaceuticals
Business
From
CNBC.com News
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
September 22, 2023
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Health care industry
From
CNBC.com News
FDA approves Pfizer maternal RSV vaccine for infants
August 21, 2023
Tags
Immunizations
Science
Business
From
CNBC.com News
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
August 02, 2023
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Walgreens Boots Alliance Inc
From
CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
July 26, 2023
Tags
Biotech and Pharmaceuticals
Vaccinations
Health care industry
From
CNBC.com News
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
June 29, 2023
Tags
Business
Pharmaceuticals
Immunizations
From
CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
June 22, 2023
Tags
Immunizations
Business
Pharmaceuticals
From
CNBC.com News
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
June 21, 2023
Tags
Business News
Health & Science
GSK plc
From
CNBC.com News
GSK says RSV vaccine for older adults provides protection over two seasons
June 21, 2023
Tags
Breaking news
Pharmaceuticals
Business
From
CNBC.com News
Pfizer RSV vaccine for older adults is only slightly less effective after 18 months
June 21, 2023
Tags
Pfizer Inc
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
FDA approves Pfizer RSV vaccine for older adults
May 31, 2023
Tags
Epidemics
US: News
Social issues
From
CNBC.com News
Here’s what Pfizer and Moderna say is next for their Covid vaccines
May 22, 2023
Tags
Science
Immunizations
Pharmaceuticals
From
CNBC.com News
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
May 18, 2023
Tags
Pfizer Inc
Biotech and Pharmaceuticals
Vaccinations
From
CNBC.com News
Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
May 16, 2023
Tags
Pharmaceuticals
Business
Science
From
CNBC.com News
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
May 03, 2023
Tags
Pfizer Inc
US: News
Moderna Inc
From
CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
February 24, 2023
Tags
Business
World News
Disease outbreaks
From
CNBC.com News
Moderna, Pfizer's new race: The RSV vaccine FDA approval process
January 18, 2023
Tags
Respiratory syncytial virus
Moderna Inc
CNBC Disruptor 50
From
CNBC.com News
A nutritionist shares the best snacks to bring on a plane to boost your immune system
December 26, 2022
Tickers
LIFE
Tags
Lifestyle
Exercise
Entertainment
From
CNBC.com News
Why flu season is so bad this year
November 10, 2022
Tickers
LIFE
Tags
Life
Business
Pharmaceuticals
From
CNBC.com News
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows
November 01, 2022
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Pandemics
From
CNBC.com News
Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV
May 11, 2022
Tickers
AZN
AZNCF
SNY
Tags
Biotech
Benzinga
Health Care
From
Benzinga
Pfizer's RSV Vaccine Candidate Receives FDA Breakthrough Therapy Tag For Prevention of RSV In Older Adults
March 24, 2022
Tickers
PFE
Tags
Market News
FDA
General
From
Benzinga
Johnson & Johnson Posts Additional RSV Vaccine Data
December 07, 2021
Tickers
JNJ
Tags
REspiratory syncytial virus
General
Market News
From
Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
October 04, 2021
Tickers
JNJ
Tags
Market News
Phase 2 Trial
General
From
Benzinga
Pfizer Starts Late-Stage Trial For RSV Vaccine Candidate In Older Patients
September 02, 2021
Tickers
PFE
Tags
General
REspiratory syncytial virus
Market News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.